These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 14728070

  • 1. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P, Broustet JP.
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [Abstract] [Full Text] [Related]

  • 2. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, Skibińska E, Szymczak K, Swiatek J, Winter M.
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [Abstract] [Full Text] [Related]

  • 3. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
    Shlyakhto EV, Almazov VV, Nifontov EM, Vakhrameyeva IV, Rudomanov OG, Zakharov DV, Kazarin VV, Vakhrameyeva NV.
    Am J Cardiovasc Drugs; 2002 Dec; 2(2):119-24. PubMed ID: 14727987
    [Abstract] [Full Text] [Related]

  • 4. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ, Plosker GL.
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
    Marzilli M, Klein WW.
    Coron Artery Dis; 2003 Apr; 14(2):171-9. PubMed ID: 12655281
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R, Ford I, Fox K, Challeton JP, Correges A, Tendera M, Widimský P, Danchin N, ATPCI investigators.
    Lancet; 2020 Sep 19; 396(10254):830-838. PubMed ID: 32877651
    [Abstract] [Full Text] [Related]

  • 7. Combination treatment with trimetazidine and diltiazem in stable angina pectoris.
    Manchanda SC, Krishnaswami S.
    Heart; 1997 Oct 19; 78(4):353-7. PubMed ID: 9404250
    [Abstract] [Full Text] [Related]

  • 8. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
    Chazov EI, Lepakchin VK, Zharova EA, Fitilev SB, Levin AM, Rumiantzeva EG, Fitileva TB.
    Am J Ther; 2005 Oct 19; 12(1):35-42. PubMed ID: 15662290
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H, Pachocki R, Domzal-Bochenska M, Szymczak K, Szydlowski Z, Paradowski A, Gajos G, Kaluza G, Kulon I, Wator-Brzezińska A, Elikowski W, Kuźniak M.
    Presse Med; 2000 Mar 18; 29(10):533-8. PubMed ID: 10761517
    [Abstract] [Full Text] [Related]

  • 10. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
    Frishman WH, Bittar N, Glasser S, Habib G, Smith W, Pordy R.
    Clin Cardiol; 1998 Jul 18; 21(7):483-90. PubMed ID: 9669057
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
    Danchin N, Marzilli M, Parkhomenko A, Ribeiro JP.
    Cardiology; 2011 Jul 18; 120(2):59-72. PubMed ID: 22122948
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
    Ferrari R, Ford I, Fox K, Marzilli M, Tendera M, Widimský P, Challeton JP, Danchin N.
    Am Heart J; 2019 Apr 18; 210():98-107. PubMed ID: 30771737
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA, Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators.
    JAMA; 2004 Jan 21; 291(3):309-16. PubMed ID: 14734593
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].
    Chaloupka V.
    Vnitr Lek; 2006 Jun 21; 52(6):609-14. PubMed ID: 16871765
    [Abstract] [Full Text] [Related]

  • 18. [Antiischemic efficacy of trimetazidine in patients with ischemic heart disease, stable angina pectoris and disturbances of carbohydrate metabolism].
    Fedotkina IuA, Panchenko EP.
    Kardiologiia; 2002 Jun 21; 42(2):28-33. PubMed ID: 12494204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.